The relationship of hyperlipidemia with maternal and neonatal outcomes in pregnancy: A cross-sectional study


Background: Concentrations of plasma lipids levels during pregnancy clearly increases. According to some studies, dyslipidemia is effective in the incidence of preeclampsia and insulin resistance.

Objective: This study aimed to examine the relationship between hyperlipidemia and maternal and neonatal outcomes in pregnant women.

Materials and Methods: This is a cross-sectional study which was conducted on two groups of pregnant women with hyperlipidemia and normal ones to assess maternal and neonatal outcomes. Maternal data including gestational age, mother’s age, body mass index, and maternal weight gain during pregnancy, gestational diabetes mellitus, preeclampsia, cholestasis, and delivery method. Also, birth weight and Apgar score were gathered as the neonatal outcomes.

Results: The results showed that the prevalence of abnormal lipid parameters increased with increasing gestational age. In pregnant women with dyslipidemia in combination with increased triglyceride, cholesterol and Low-density lipoprotein, and decreased High-density lipoprotein, the incidence rates of gestational diabetes (p < 0.001), preeclampsia (p < 0.001), cholestasis (p = 0.041), fetal growth retardation (p < 0.001), and macrosomia (p < 0.001) were statistically higher.

Conclusion: Dyslipidemia was associated with some adverse effects of pregnancy and harmful fetal outcomes. Therefore, it seems that adding laboratory assessment of lipid profiles before and during pregnancy can be effective in early diagnosis of dyslipidemia.

Key words: Dyslipidemias, Gestational diabetes, Preeclampsia, Fetal macrosomia.

[1] Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta−analysis. BJOG 2015; 122: 643–651.

[2] Enquobahrie DA, Williams MA, Qiu C, Luthy DA. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract 2005; 70: 134–142.

[3] Li G, Kong L, Zhang L, Fan L, Su Y, Rose JC, et al. Early pregnancy maternal lipid profiles and the risk of gestational diabetes mellitus stratified for body mass index. Reprod Sci 2015; 22: 712–717.

[4] Qiu C, Rudra C, Austin MA, Williams MA. Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res 2007; 56: 571–578.

[5] Iimura Y, Matsuura M, Yao Z, Ito S, Fujiwara M, Yoshitsugu M, et al. Lack of predictive power of plasma lipids or lipoproteins for gestational diabetes mellitus in Japanese women. J Diabetes Invest 2015; 6: 640–646.

[6] Mann D, Zipes D, Libby P, Bonow R. Braunwalds heart disease: A textbook of cardiovascular medicine, single volume. 10th Ed. Boston: Harcoupt Brace; 2005.

[7] Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: 290–296.

[8] Schaefer-Graf UM, Kjos SL, Kilavuz O, Plagemann A, Brauer M, Dudenhausen JW, et al. Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care 2003; 26: 193–198.

[9] Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-for gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010; 89: 700–704.

[10] Sovio U, Murphy HR, Smith GC. Accelerated fetal growth prior to diagnosis of gestational diabetes mellitus: a prospective cohort study of nulliparous women. Diabetes Care 2016; 39: 982–987.

[11] Liu D, Wang Y, Li R, Dai ZY, Zhou R, Liu J, et al. Effect of plasma lipids on gdm in the first trimester of pregnant women: a prospective cohort study. Sichuan Da Xue Xue Bao Yi Xue Ban 2016; 47: 64–67.

[12] Saraswat N, Wal P, Sachan N, Chandra P. Pregnant woman; diabeties complications. J Drug Discover Dev 2017; 1: 37–39.

[13] American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003; 26: 103–105.

[14] Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth 2016; 16: 60–68.

[15] Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 2002; 19: 43–55.

[16] Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol 1992; 45: 27–35.

[17] Wang C, Zhu W, Wei Y, Su R, Feng H, Lin L, et al. The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J Diabetes Res 2016; 2016: 3013567.

[18] Li C, Kaur H, Choi WS, Huang TT, Lee RE, Ahluwalia JS. Additive interactions of maternal pregnancy BMI and breast-feeding on childhood overweight. Obstet Res 2005; 13: 362–371.

[19] Robillard PY, Dekker G, Chaouat G, Hulsey TC. Etiology of preeclampsia: maternal vascular predisposition and couple disease–mutual exclusion or complementarity? J Reprod Immunol 2007; 76: 1–7.

[20] Billionnet C, Mitanchez D, Weill A, Nizard J, Alla F, Hartemann A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 2017; 60: 636–644.

[21] Hancerliogullari N, Celik HK, Karakaya BK, Tokmak A, Tasci Y, Erkaya S, et al. Effect of prolonged fasting duration on 50 gram oral glucose challenge test in the diagnosis of gestational diabetes mellitus. Horm Metab Res 2018; 50: 671–674.

[22] Wang Q, Würtz P, Auro K, Mäkinen VP, Kangas AJ, Soininen P, et al. Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med 2016; 14: 205.